Artūrs Ābols

1.1k citations
26 papers · 870 indexed · h-index 12
Topics
Extracellular vesicles in disease (10 papers)MicroRNA in disease regulation (6 papers)RNA Interference and Gene Delivery (4 papers)
Partner nations
LatviaNorwayItaly

In The Last Decade

Artūrs Ābols

26 papers receiving 864 citations

Peers

Artūrs Ābols
Comparison fields: 5 of 85
  • Molecular Biology 683
  • Cancer Research 450
  • Immunology 124
  • Biomedical Engineering 116
  • Oncology 83
Replace Yeoun Jin Kim with:
Yeoun Jin Kim United States
Edgars Endzeliņš Latvia
Marta Sesé Spain
Claudia Felici Italy
Wasim H. Chowdhury United States
Maoye Wang China
Maggie K. S. Tang Hong Kong
Junko Kano Japan
Denisa Dragu Romania
Htoo Zarni Oo Canada
Artūrs Ābols relative to Yeoun Jin Kim United States Yeoun Jin Kim's profile →
Citations per field
00.5×1.5×2.2×
Yeoun Jin Kim · 1×
Citations per year

Countries citing papers authored by Artūrs Ābols

Since Specialization
Citations

This map shows the geographic impact of Artūrs Ābols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Artūrs Ābols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Artūrs Ābols more than expected).

Fields of papers citing papers by Artūrs Ābols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Artūrs Ābols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Artūrs Ābols. The network helps show where Artūrs Ābols may publish in the future.

Co-authorship network of co-authors of Artūrs Ābols

This figure shows the co-authorship network connecting the top 25 collaborators of Artūrs Ābols. A scholar is included among the top collaborators of Artūrs Ābols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Artūrs Ābols. Artūrs Ābols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 5
3 3
4 11
5 37
6 122
7 10
8 44
9 96
10 1
11 23
12 1
13 15
14 210
15 10
16 48
17 67
18 7
19 71
20 41

About Artūrs Ābols

Artūrs Ābols is a scholar working on Cancer Research, Biophysics and Molecular Biology, having authored 26 papers that have together received 870 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (10 papers), MicroRNA in disease regulation (6 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Cancer Research (450 citations), Molecular Biology (683 citations) and Immunology (124 citations). Artūrs Ābols has collaborated with scholars based in Latvia, Norway and Italy. Frequent co-authors include Aija Linē, Edgars Endzeliņš, Alicia Llorente, M. Helena Vasconcelos, Hugo R. Caires, Cristina P. R. Xavier, Cristina Bajo-Santos, Marta Rodríguez, Andreas W. Berger and Daiga Šantare. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Immunological Methods and The Analyst.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026